New Zealand News
Aspen Announces Multi-Territory Acquisition Of GSK OTC Products
Australian News, New Zealand News, Media Release
Aspen has acquired a range of OTC products from GSK in a multi-territory transaction.
For Australia, the basket of products has sales of around $17 million, with about $750K in New Zealand. Other Asia-Pacific countries coming under the Aspen Australia umbrella represent sales of around $13.5 million.
The products in Australia are Cartia, Zantac, Lipeze, Quellada and Beconase, all well known power brands which will cement the position of Aspen Australia as one of the leading OTC companies in the country.
Aspen Launch Philippines Business
Australian News, New Zealand News, Media Release
Aspen, Africa’s largest pharmaceutical manufacturer and the biggest listed pharmaceutical group in the health care sector of the Johannesburg Stock Exchange, through Aspen Pharmacare Australia, one of the leading pharmaceutical companies in Australia, aims to make high-quality branded medicine available to Filipino patients at affordable cost through the launch of its local subsidiary, Aspen Philippines.
South China Morning Post Article
Australian News, New Zealand News, Media Release
In a span of 11 years, Aspen Pharmacare Australia has become one of Australia's leading pharmaceutical companies, developing a reputation for reliable, regulated and affordable medicines. Aspen-marketed brands account for one out of seven prescriptions written in the country.
Business Review Australia Article
Australian News, New Zealand News, Media Release
Aspen Pharmacare Australia Expanding Global Business - from recent acquisition to expansion plans in Asia, Aspen Pharmacare Australia is ready to increase sales and markets.
Aspen Acquires Sigma's Pharmaceutical Business For AU$900 Million
Australian News, New Zealand News, Media Release
Aspen, South Africa's leading pharmaceutical company, has announced that all conditions precedent have been met for it to acquire the pharmaceutical business of Australian-based Sigma Pharmaceuticals Limited.
Stephen Saad, CEO of Aspen Holdings, comments on Sigma purchase
Australian News, New Zealand News, Announcements
An interview of Stephen Saad, CEO of Aspen Holdings.
Diversity and Flexibility eNews
Australian News, New Zealand News, Media Release
Aspen's high level of flexibility has shown demonstrable business outcomes in addition to the attraction/retention of diverse talent, including consistently meeting sales objectives and extremely high value customer relationships.
